What Faspic (Ibuprofen) Treats: Main Uses and Benefits

Faspic is a formulation of ibuprofen, a medicine belonging to the class of nonsteroidal anti-inflammatory drugs (NSAIDs). Its core therapeutic domain involves analgesic, anti-inflammatory, and antipyretic activity. This is commonly used for managing symptoms related to physical discomfort, inflammatory states, and systemic imbalance.

Ibuprofen is applied in addressing symptoms that interfere with daily functioning and those related to heightened physiological activity. It is commonly used to help with symptom clusters such as those associated with the common cold, backache, toothache, and muscular aches. It also plays a role in managing pain and irritation associated with conditions characterized by periods of heightened symptoms, including arthritis and primary dysmenorrhea (menstrual cramps).

It may be considered relevant in contexts involving heightened systemic burden where supportive relief is needed: “Ibuprofen may be part of symptomatic management for a variety of conditions presenting with systemic or localized discomfort.”

This supports the process of easing discomfort and reducing the body's reaction to irritative states. Ibuprofen may assist with easing the overall symptom load and supports general well-being during symptomatic phases.

Key Use: Supports general well-being during symptomatic phases

Regulatory References

1. NIH MedlinePlus Drug Information

Official Eligibility Rules for Faspic (Ibuprofen)

Faspic (Ibuprofen) eligibility is defined by regulatory bodies, establishing specific groups who must not use the medicine (contraindications) and groups for whom use is restricted.

Absolute Contraindications

Faspic is contraindicated and must not be used by individuals with a history of hypersensitivity to ibuprofen, aspirin, or any other NSAID. It is also prohibited for patients with active or recurrent peptic ulceration or gastrointestinal hemorrhage, severe heart failure (NYHA Class IV), severe hepatic failure, or severe renal failure. Use is also prohibited during the last trimester of pregnancy and for peri-operative pain after Coronary Artery Bypass Graft (CABG) surgery.

Age and Conditional Use

Use requires caution and monitoring for patients with a history of GI disease, uncontrolled hypertension, mild-to-moderate organ impairment, or Systemic Lupus Erythematosus (SLE). The medicine is not recommended for women actively trying to conceive.

Interactions with other medicines and products

Ibuprofen, the active ingredient in Faspic, is associated with specific, officially documented interaction patterns that primarily involve altered clearance of other medicines, changes in plasma exposure, or increased risk of adverse effects through pharmacodynamic reinforcement. All interaction information is aligned with regulatory prescribing information.

Formal Contraindicated Combinations

Co-administration with other NSAIDs, including COX-2 selective inhibitors, is formally contraindicated due to the significantly increased risk of serious gastrointestinal bleeding. This prohibition also applies to co-use with Aspirin at analgesic doses (ge 325 mg). The risk of hemorrhage is also increased when Ibuprofen is combined with Anticoagulants (e.g., Warfarin), Antiplatelet agents, or SSRIs.

Pharmacokinetic and Clearance Interactions

Ibuprofen can increase the plasma concentrations of medicines like Lithium, Digoxin, and Methotrexate by reducing their renal clearance. Co-administration with potent CYP2C9 Inhibitors (e.g., Fluconazole) decreases Ibuprofen clearance, leading to increased systemic exposure ( AUC and C max) of Ibuprofen itself. Separately, the antihypertensive and diuretic effects of ACE Inhibitors and Diuretics may be reduced by Ibuprofen.

Timing Restriction and Substance Interaction

A mandatory time separation is specified for co-administration with low-dose Aspirin (antiplatelet dose le 100 mg) to prevent interference with Aspirin’s effect. Ibuprofen must be taken at least 8 hours before or 30 minutes after immediate-release low-dose Aspirin. The regulatory labeling also documents an increased risk of gastrointestinal bleeding when co-administered with alcohol.

Faspic is classified as a non-steroidal anti-inflammatory drug (NSAID). Its core mechanism of action is functioning as a reversible, non-selective inhibitor of the cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. By binding to and blocking the active site of these enzymes, Faspic impairs the enzymatic conversion of arachidonic acid within cells. This action leads to a measurable decrease in the biosynthesis of prostanoids—a class of eicosanoids that includes prostaglandins, thromboxanes, and prostacyclins. The resultant attenuation of prostanoid synthesis modulates downstream physiological signaling pathways. This inhibition cascade is the fundamental molecular process that reduces the localized production of inflammatory mediators within targeted tissues, thereby altering cellular and systemic responses.

The administration of Faspic (Ibuprofen) is defined by protocols that establish the authorized route, dosing boundaries, and specific intake conditions. The medicine is primarily taken via the oral route, with film-coated tablets intended to be swallowed whole using a glass of water. Granules contained in sachets must be prepared by dissolving the content completely in water prior to ingestion.

Dosing and Schedule

The standard starting dose for an adult is 200 mg or 400 mg. Dosing requires a minimum interval of four to six hours between doses to align with established schedules. The fundamental principle guiding its use is to utilize the lowest effective dose for the shortest possible duration. The maximum daily dose for general non-prescription use is restricted to 1200 mg within any 24-hour period, although higher prescription doses (up to 3200 mg) are documented for the acute phase of certain chronic inflammatory conditions.

Contextual and Population Rules

Faspic is recommended to be taken with or immediately after food. For self-management of acute symptoms, the duration of use is limited to 10 days for pain or 3 days for fever. Adolescents (ge 12 years or ge 40 kg) typically follow the initial adult dosing regimen. Population-specific rules mandate that older adults and those with mild hepatic or renal impairment use the lowest possible dose. If a dose is missed, it should be taken as soon as it is remembered, provided the minimum 4-hour dosing interval can be maintained, without administering a double dose.

Research evidence / Overview of studies for Faspic (Ibuprofen)

Research Evidence from Clinical Trials for Acute Pain and Fever

The evidence base for Ibuprofen related to general short-term discomfort and fever comes from a large volume of research, including many well-established Randomized Controlled Trials (RCTs) and subsequent systematic reviews. These studies focus on populations of adults and children presenting with conditions characterized by episodic or acute changes in their symptoms.

Research examined how patient-reported outcomes describing perceived discomfort and objective measures like body temperature evolved in the observed populations over specific, short time intervals. Findings describe patterns observed in the studies that contribute to the broader evidence landscape related to outcomes related to physical discomfort and systemic imbalance.

Research on the Fast-Acting Arginine Formulation

Faspic, which contains a formulation of Ibuprofen, has been the subject of dedicated research. These studies were primarily pharmacokinetic trials, which examined the absorption profile of the medicine in the body. Research explored the difference in the time to reach maximum concentration (T max) in the bloodstream when compared to the standard Ibuprofen free acid. These studies focused on episodes where symptoms become more noticeable, such as in dental pain, and observed patterns related to a shorter measured time until participants reported initial relief.

Research Evidence from Studies of Inflammatory Conditions

Research related to Ibuprofen was conducted in trials designed to evaluate outcomes associated with conditions like arthritis and primary dysmenorrhea. These studies often include populations of adults with established conditions marked by functional limitations and cycles of fluctuating symptom intensity.

Study Duration, Follow-up, and Outcome Maintenance

Research has explored both single-dose use for acute pain and extended observation periods for chronic conditions. For acute uses, the follow-up durations were limited to the immediate period after administration or the first few days.

For conditions requiring extended use, such as arthritis, studies have monitored patients over periods ranging from several weeks to multiple years. However, the evidence derived from these extended settings often has the dual purpose of assessing both the maintenance of outcomes related to systemic or functional imbalance and the research endpoints related to tolerance and sustained use. As such, the isolated study of the outcome maintenance is not always fully established, and long-term effects are not fully established outside of safety reporting.

Evidence in Different Patient Groups (Special Populations)

Research has included children and adolescents (typically ge 6 months of age) in studies exploring acute pain and fever. This evidence helps show what has been observed so far for outcomes associated with physical discomfort in these younger age groups.

Research Gaps and Unanswered Questions

While there is a large body of evidence for Ibuprofen, research still contains some limitations and areas where certainty remains low. One key limitation is that for many acute pain studies, the follow-up durations were limited to short observation windows, as the full pattern of symptom evolution beyond the first few hours or days is less clearly characterized. The evidence quality varies across studies, and some subgroup findings are uncertain due to small sample sizes in specific trials.

Common questions about Faspic (Ibuprofen) (FAQ)

Q: What is Faspic (Ibuprofen) used for?

A: Faspic is a medication that contains ibuprofen combined with an amino acid called arginine. It belongs to a class of drugs known as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Faspic is used for the symptomatic relief of mild to moderate pain that is also accompanied by inflammation.

Specific uses can include relieving pain and inflammation from conditions like:

• Headaches (including migraines)
• Toothache
• Muscle pain or soft tissue injuries
• Menstrual pain (dysmenorrhea)

Q: How does Faspic work?

A: Faspic works by inhibiting the production of certain natural substances in the body called prostaglandins. Prostaglandins are chemical messengers that are released at the site of injury and cause pain, swelling, and fever.

By blocking the enzyme responsible for making prostaglandins (cyclooxygenase, or COX), Faspic helps to reduce inflammation, lessen pain, and lower fever.

The addition of arginine in Faspic is believed to help the ibuprofen dissolve and be absorbed into the bloodstream more quickly, leading to a faster onset of pain relief compared to standard ibuprofen tablets.

Q: What are common side effects of Faspic (Ibuprofen)?

A: Like all medicines, Faspic can cause side effects, though not everyone experiences them. Common side effects often involve the digestive system and may include:

• Indigestion (dyspepsia)
• Heartburn
• Abdominal pain or discomfort
• Nausea or vomiting
• Diarrhea or constipation
• Flatulence (gas)

Other common side effects can include headache or dizziness.

To minimize the risk of digestive side effects, Faspic is often recommended to be taken with food or milk.

Q: Who should not take Faspic?

A: You should not take Faspic if you have:

• An allergy or hypersensitivity to ibuprofen, arginine, aspirin, or any other NSAID.
• A current or history of a stomach ulcer, perforation, or bleeding in the stomach or intestines related to previous NSAID use.
• Severe heart failure, liver failure, or kidney failure.
• A history of asthma, rhinitis, or hives after taking aspirin or other NSAIDs.
• A condition causing unusual bleeding or are taking certain anticoagulant (blood thinner) medications.
• You are in the last trimester of pregnancy (from the 20th week).

It is important to always consult a healthcare professional before starting any new medication, especially if you have pre-existing medical conditions.

Storage and Disposal of Faspic (Ibuprofen)

Official regulatory information defines specific conditions for storing and disposing of Ibuprofen products like Faspic.

Storage Requirements

Faspic must be stored at Controlled Room Temperature, typically 20 C to 25 C, and not above 25 C. Storage must avoid excessive heat above 40 C. The product must be stored in the outer carton or original packaging to ensure protection from light and moisture. Any bottle must be kept tightly closed.

Handling and Safety

It is required to Keep out of the sight and reach of children.

Disposal Instructions

Unused or expired product must be disposed of in accordance with local requirements. The preferred method is often returning leftover medicine to a pharmacist. Disposal must not include flushing the medicine down a sink or toilet unless explicitly advised by regulatory guidance.